Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE

ACETAMINOPHEN; BUTALBITAL; CAFFEINE

Standard Dose
500MG;50MG;40MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is listed in Drugs@FDA under application 040261 (ANDA).

Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL; CAFFEINE Form and strength CAPSULE;ORAL - 500MG;50MG;40MG Sponsor HIKMA Submission history Latest submission status date: 1998-10-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is listed in Drugs@FDA under application 040261 (ANDA). Marketing status: Discontinued Active ingredient ACETAMINOPHEN; BUTALBITAL; CAFFEINE Form and strength CAPSULE;ORAL - 500MG;50MG;40MG Sponsor HIKMA Submission history Latest submission status date: 1998-10-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (ACETAMINOPHEN; BUTALBITAL; CAFFEINE) | Drug Monograph | MedicHelpline